Physician

Maneesh C. Kanal, MD

According to 2025 Medicare claims, Maneesh Kanal, MD (NPI: 1700271012) practices internal medicine in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Polk, MN. This provider's primary affiliated billing organization is RIVERVIEW HEALTHCARE ASSOCIATION (NPI: 1487944898; TIN: 410724029) and primary practice location at 56716-1601. Kanal is affiliated with the Essentia Health ACO, Inc. (ACO ID: A5617) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kanal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 75 traditional Medicare patients, billed 194 HCPCS/CPT codes, and received $13,280 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,755 prescription claims across 270 beneficiaries totaling $245,247 in drug costs, led by Xarelto (Rivaroxaban). DME data shows 59 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,788 and ending at $13,280. Concurrently, Part D prescription costs have risen steadily, from $1,867 to $245,247. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $437 and ending at $7,052.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	18	35	$1,788
2019	52	132	$7,531
2020	100	267	$12,480
2021	91	191	$11,188
2022	108	225	$12,222
2023	65	109	$5,933
2024	75	194	$13,280

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	45	$1,867
2016	45	133	$4,333
2017	133	256	$17,339
2018	62	205	$8,014
2019	143	1,038	$49,629
2020	188	2,111	$194,462
2021	266	4,139	$257,589
2022	317	4,868	$340,495
2023	316	4,986	$348,662
2024	270	3,755	$245,247

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	248	$9,915
2021	14	73	$3,295
2022	11	88	$4,746
2023	N/R	119	$9,339
2024	N/R	59	$4,283

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	21	23	$96
90662	Influenza vaccine split virus, preservative free	17	18	$79
99238	Hospital discharge day management, 30 minutes or less	26	30	$61
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	14	21	$38
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	21	21	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	39	1,294	$23,373
Eliquis	Apixaban	12	840	$15,499
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	570	$11,481
Spiriva Respimat	Tiotropium Bromide	17	630	$10,569
Breo Ellipta	Fluticasone/Vilanterol	17	690	$8,808

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	11	$3,646
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	11	$285
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	19	$196
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	18	$157

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Maneesh C. Kanal, MD?

Tedicare shows public-source Medicare data for Maneesh C. Kanal, MD (NPI 1700271012), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maneesh C. Kanal, MD have ACO affiliation data?

Maneesh C. Kanal, MD is shown with ACO affiliation data for Essentia Health ACO, Inc. (MSSP, ACO ID A5617) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Maneesh C. Kanal, MD?

Maneesh C. Kanal, MD is linked to RIVERVIEW HEALTHCARE ASSOCIATION (billing NPI 1487944898) in the available physician profile data.

Does Maneesh C. Kanal, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.